CLINICAL TRIALS PROFILE FOR FINASTERIDE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for FINASTERIDE
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| New Combination | NCT06944145 ↗ | New Treatment Strategies and Epigenetic Biomarker for Management of BPH | NOT_YET_RECRUITING | Beth Israel Deaconess Medical Center | PHASE2 | 2025-10-01 | SRD5A2 is a critical enzyme for prostatic development and growth, and the SRD5A2 inhibitor, finasteride, is used to treat benign prostatic hyperplasia (BPH). SRD5A2 is absent in 30% of normal adult men, which explains the resistance of a subset of patients to this commonly prescribed drug. This project proposes new combination therapies (5-ARI+raloxifene) and evaluates novel non-invasive biomarkers, based on alternative pathways that lead to prostatic enlargement. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for FINASTERIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | Cancer and Leukemia Group B | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | Eastern Cooperative Oncology Group | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | National Cancer Institute (NCI) | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | NCIC Clinical Trials Group | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FINASTERIDE
Condition Name
Clinical Trial Locations for FINASTERIDE
Trials by Country
Clinical Trial Progress for FINASTERIDE
Clinical Trial Phase
Clinical Trial Sponsors for FINASTERIDE
Sponsor Name
